Clinical Trial Update: Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing whether adding liraglutide to short-term insulin infusion improves long-term glycemic remission and beta-cell function i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• liraglutide (liraglutide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN